Reclassification of comparatives

12 Months Ended

Jun. 30, 2023

Note 5. Reclassification of comparatives

During the preparation of the financial statements for the current year, a reclassification between borrowings and other assets was performed to better reflect the insurance funding premium utilized by the Company, a reclassification of

non-current

annual leave employee benefit to current employee benefits and a reclassification between loss on remeasurement of contingent consideration and general and administrative expense to accurately reflect the impact of the unwinding of discounting contingent consideration for paxalisib.


	30 June 2022 Restated			Reclassification			30 June 2022 Reclassified

Other assets		156			1,841			1,997
Borrowings		—			(1,841	)		(1,841	)
Current employee benefits		166			203			369
Non-current employee benefits		319			(202	)		117
Loss on remeasurement of contingent consideration		153			153			—
General and administrative expense		(4,961	)		(153	)		(5,114	)